The clinical efficacy and side-effects of mianserin and nortriptyline in depressed out-patients: a double-blind randomized trial.

Author: HocJ

Paper Details 
Original Abstract of the Article :
A double-blind randomized study was performed in 86 depressed out-patients, in order to compare the efficacy and tolerance of mianserin (30 to 60 mg daily) with that of nortriptyline (75 to 150 mg daily). Both drugs were administered for 6 weeks after a wash-out period of 1 week. The Hamilton Rating...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1185/03007998209109779

データ提供:米国国立医学図書館(NLM)

Mianserin vs. Nortriptyline: A Desert Race for Depression Relief

The desert of depression can be a lonely and isolating place, leaving many seeking relief. This double-blind randomized trial, like a desert race, pits two medications, [mianserin and nortriptyline], against each other to see which one can offer the most effective path to recovery. The researchers found that [both medications were effective in treating depressed out-patients], offering a valuable oasis of relief in this challenging landscape.

A Neck-and-Neck Race

The study found that [both mianserin and nortriptyline had similar efficacy in reducing depressive symptoms], with [mianserin demonstrating better tolerability]. This is like a camel race where both competitors reach the finish line, but one camel is less likely to suffer from side effects. This suggests that [mianserin may offer a more comfortable and better-tolerated treatment option for depression], offering a smoother and more enjoyable journey through the desert of mental health.

Navigating the Desert of Depression

This research emphasizes the importance of [individualized treatment approaches] for depression, recognizing that each patient's journey through the desert of mental health is unique. It's like recognizing that each traveler in the desert needs a different approach, taking into account their specific needs and preferences. By working with a healthcare professional, patients can find the best oasis of treatment options to alleviate their symptoms and improve their quality of life.

Dr. Camel's Conclusion

This study is a valuable guide for navigating the desert of depression. It reminds us that we have valuable tools at our disposal, like mianserin and nortriptyline, that can help us find relief from this challenging condition. By approaching depression with early intervention and appropriate treatment, we can potentially reduce the suffering and ensure a smoother and more comfortable journey for our patients.

Date :
  1. Date Completed 1983-03-24
  2. Date Revised 2019-09-08
Further Info :

Pubmed ID

6759061

DOI: Digital Object Identifier

10.1185/03007998209109779

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.